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Background: The capture and use of disease-related anatomic pathology data for both model organism phenotyping
and human clinical practice requires a relatively simple nomenclature and coding system that can be integrated into
data collection platforms (such as computerized medical record-keeping systems) to enable the pathologist to rapidly
screen and accurately record observations. The MPATH ontology was originally constructed in 2,000 by a committee of
pathologists for the annotation of rodent histopathology images, but is now widely used for coding and analysis of
disease and phenotype data for rodents, humans and zebrafish.
Construction and content: MPATH is divided into two main branches describing pathological processes and
structures based on traditional histopathological principles. It does not aim to include definitive diagnoses, which
would generally be regarded as disease concepts. It contains 888 core pathology terms in an almost exclusively is_a
hierarchy nine layers deep. Currently, 86% of the terms have textual definitions and contain relationships as well as
logical axioms to other ontologies such the Gene Ontology.
Application and utility: MPATH was originally devised for the annotation of histopathological images from mice but
is now being used much more widely in the recording of diagnostic and phenotypic data from both mice and
humans, and in the construction of logical definitions for phenotype and disease ontologies. We discuss the use of
MPATH to generate cross-products with qualifiers derived from a subset of the Phenotype and Trait Ontology (PATO)
and its application to large-scale high-throughput phenotyping studies. MPATH provides a largely species-agnostic
ontology for the descriptions of anatomic pathology, which can be applied to most amniotes and is now finding
extensive use in species other than mice. It enables investigators to interrogate large datasets at a variety of depths,
use semantic analysis to identify the relations between diseases in different species and integrate pathology data with
other data types, such as pharmacogenomics.
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Since the late eighteenth century when achromatic
lenses and reliable histological stains began to be avail-
able, investigators of anatomic pathology, and particu-
larly in the mid -nineteenth century the innovators of
cellular pathology such as Rudolf Virchow, developed
and applied terminologies to describe their observations
[1,2]. These depended on the “school” to which the pa-
thologists belonged, but more importantly on the etio-
logic or mechanistic paradigm in which they were* Correspondence: ps@mole.bio.cam.ac.uk
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reproduction in any medium, provided the orworking [3]. One of the great achievements of the nine-
teenth century was the recognition of the universality of
pathological processes and entities and their occurrence
in multiple species as recognisable manifestations of the
same underlying processes [4]. It was, nevertheless, a
century before broadly accepted and rationally struc-
tured pathology terminologies were developed (e.g. [5]).
The development of pathology terminologies has to an
extent occurred independently of disease terminologies
and nosologies, partly as a result of the much longer his-
tory of classifying diseases, and partly due to the
inherited preconceptions of the nature of disease in clin-
ical medicine.
The distinction between pathological and clinical de-
scriptions of disease, disorders and predispositions is stillal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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have been attempts to rationalise the definitions of these
concepts [6] and their relation to each other as part of a
broadly applicable model of disease other than an un-
structured collection of manifestations or phenotypes
which are found in that class of individuals forming the
basis of a diagnosis. Issues about severity, time course,
organ involvement etc. are beginning to be addressed,
but it is remarkable that even treating diseases as a “bag“
of phenotypes has been shown to provide a powerful ap-
proach in establishing the relationships between dis-
eases, and the presence of related diseases in different
organisms [7-10]. What has recently been identified as
important, nevertheless, is that the tissue-specific reso-
lution of the recording of lesions, and the ability to rec-
ord the pattern of disease within an individual, has
proved vital for GWAS mapping of predisposing genetic
variants in inbred strains of mice allowing each class of
lesion to be analysed in isolation [11,12].
The discipline of pathology may be broken down into
clinical and anatomic pathology, the former is concerned
with clinical chemistry, hematology, clinical microbiol-
ogy and emerging sub-specialities such as molecular
diagnostics and proteomics. The latter, which forms the
domain of MPATH, deals with the histological, histochem-
ical or immunohistochemical observations of alterations
in tissue composition or architecture. Both branches of
the medical specialty, which are increasingly merging, may
be viewed as aspects of phenotyping, and both provide
subtypes of the clinical signs associated with ongoing dis-
ease processes, the results of developmental abnormalities,
or the historical presence of disease.
Anatomic pathology nomenclature and its applications
The universality of the repertoire of responses to under-
lying genetic or extrinsic insults means that gross and
histopathologically-defined phenotypes are some of the
most useful phenotypes for relating diseases between dif-
ferent species, and constitute some of the most species-
agnostic phenotype descriptors. This makes a pathologic
term-based ontology a crucial tool in experimental and
clinical phenotype data capture [13].
The development of systematic human pathologic no-
menclatures has been driven by the efforts of the American
College of Pathologists, initially with the development of
the pathology specific nomenclature (SNOP) over 40 years
ago [14] to the current SNOMED –CT with cross refer-
ences to UMLS, the NCI thesaurus and other terminolo-
gies. The ICD [15], now in its 11th revision and the
associated ICD-O v-3 for cancer, also contains descrip-
tions of many pathological lesions.
The other driver for pathologic terminology standard-
isation has been coding of lesions from toxicopathology.
The American Society of Toxicopathology (STP) workingwith Registry of Industrial Toxicology Animal-data (RITA)
database group in Europe has produced several inter-
nationally accepted nomenclature systems, particularly fo-
cusing on proliferative lesions. Recently, the STP has
undertaken a major harmonization exercise for rodent
pathology – the INHAND (International Harmonization
of Nomenclature and Diagnostic Criteria for Lesions in
Rats and Mice) initiative [16]. So far this group has
reported on the hepaticobiliary, respiratory, nervous and
urinary systems [17-20]. For some time the National Can-
cer Institute’s Mouse Models of Human Cancer consor-
tium (MMHCC) has been examining the classification of
tumours in genetically engineered mice. MMHCC has
produced a consensus base terminology for neoplasias of
the major organ systems that have been presented in a
series of papers over the last decade [21].
Despite the huge value of these resources, none is cur-
rently constructed as an ontology with meaningful ax-
ioms to support inference and automated reasoning, and
to that end we developed MPATH to describe lesions
that arise in laboratory mice.
Construction and content
The MPATH ontology was constructed ab initio by a
group of clinical and veterinary pathologists in 2,000 and
has since been revised and augmented by an evolving
group of US and European pathologists on a regular
basis. It is clear from more than a decade of experience
that expert input and manual curation are essential to
generate an accurate and functional resource. One strat-
egy for building the ontology has been to integrate it
into large-scale phenotyping and diagnostic programs so
that the pathologists use it on a daily basis and have
fields to add missing terms or synonyms that they are
more familiar with thereby constantly increasing its
coverage and utilitarian value.
MPATH contains 888 classes in an almost exclusively
is_a hierarchy eight layers deep. Part_of relations are used
only in the case of, for example, adenomatous polyp
(MPATH:490) and intraductal papilloma (MPATH:285)
where pathologists distinguish between a macroscopic le-
sion (“–osis”) and individual lesions which make them up;
both need to be described. The top level distinction in
MPATH is between pathophysiology (pathological pro-
cesses) and anatomic pathology (pathological entities).
One issue met frequently in development was the normal
practice of referring to observation of a physical lesion by
using the process term; for example “necrosis” or “scler-
osis”. Thus the noun describing the real-world entity ob-
served is homonymous with the inferred process. This
problem has been addressed through the textual and lo-
gical definitions of terms but is a recurrent source of con-
fusion in formal treatments of pathology nomenclature.
Pathologists using MPATH almost exclusively use the
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ception of describing inflammation or other general pro-
cesses where the process is described using qualifiers such
as “acute” which are logically process-specific, consistent
with the use of Phenotype And Trait Ontology (PATO)
[22] qualifiers (see below). The upper levels of MPATH’s
anatomic pathology branch include six broad domains fa-
miliar to all traditions of pathology training and compre-
hensively covering all known lesions; cell and tissue
damage, circulatory disorder, developmental and structural
abnormality, growth and differentiation defect, healing
and repair structure, and neoplasm, and are as orthogonal
as is feasible given the complexities of pathobiology (see
Figure 1A). The upper levels of MPATH’s pathophysiology
branch denote pathological processes that underlie lesions
and include six broad domains; cell and tissue damage
process (see Figure 1C), defective growth and differenti-
ation process, developmental process abnormalities,
healing and repair process, immunopathological process,
and neoplasia. All pathological processes and entities can
be placed within these upper level domains, which will
be familiar to all pathologists and are common to all
amniotes.
Relationship to upper level and other ontologies
MPATH is largely congruent with the upper level Ontol-
ogy for General Medical Science (OGMS) [6], founded
on the Basic Formal Ontology (BFO). Pathological bodily
process (OGMS:0000061) and pathological anatomicalFigure 1 Structure of MPATH. A; overall structure of the top level classes
entity for the major divisions. B; polyhierarchy showing multiple parentage
and morphological classification. C; cell and tissue damage process segmenstructure (OGMS:0000077) are broadly mappable to the
upper levels of MPATH; MPATH:603 (pathological ana-
tomical entity) and MPATH: 596 (pathological process) re-
spectively. However, more detailed mapping is difficult.
For example the MPATH experts view congenital malfor-
mations as pathological anatomical structures, whereas
OGMS views them as distinct, and similarly MPATH
views inflammation as a pathological process whereas
OGMS does not include this as a pathological bodily
process. Until such discrepancies are resolved, integra-
tion of MPATH into the OGMS framework will be
problematical.
From the point of view of application, the most import-
ant mappings for MPATH are to the Human Phenotype
Ontology (125), the Mammalian Phenotype ontology
(111), the Disease Ontology (231), SNOMED-CT (867)
and the NCIt (566), reflecting the emphasis on the domain
of anatomic pathology rather than disease.
Definitions and axiomatic relationships
Currently, 86% of classes have textual definitions. Each
class is in the mouse pathology namespace and is
uniquely identified by a URI of the form: http://purl.
obolibrary.org/OBO/MPATH_n. The main ontology is
available in both the OBO Flatfile Format and the Web
Ontology Language (OWL). MPATH is housed in a sub-
version repository and is made available via OBO registry,
Bioportal (http://purl.bioontology.org/ontology/MPATH)
and on the project’s website http://mpath.googlecode.com/.in MPATH showing division into pathological process and physical
for some anatomically predicated tumor classes and their anatomical
t of MPATH showing main pathological process classes in this branch.
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other ontologies such the Gene Ontology (GO) [23], Cell
Type ontology (CL) [24] and the Phenotype And Trait
Ontology (PATO) [22]. For example, the MPATH term
transitional cell metaplasia (MPATH:172) represents a
metaplastic response of the transitional epithelium, for ex-
ample in the bladder to give squamous metaplasia and
glandular metaplasia. To allow computational access to
these relations, we use the derives-from relation and relate
metaplasia (MPATH:549) (an MPATH term that denotes
an abnormal transformation of a differentiated adult
cell or tissue of one kind into a differentiated tissue of
another kind) with the CL term transitional epithelial
cell (CL:0000244).
Application and utility
A post-composition strategy for pathology coding
Traditionally pathologists have relied on a narrative form
of recording their definitive diagnoses, making use of
morphologic, etiologic, and disease-based terms that col-
lectively provide a diagnosis useful for clinical patient
management. This is particularly important for non–
neoplastic lesions where it can be complex to capture
important subtleties of distribution, severity, microscopic
sub-type and anatomical location for example. Whilst
this is the gold standard, it is not possible to compute
on data recorded in this way and it is very difficult to
tabulate and quantitatively analyse the collected infor-
mation. There are strong arguments, mainly from ex-
perience in toxicologic pathology, that a descriptive
(anatomic) rather than diagnostic coding is the most ob-
jective and useful way to code pathology-based observa-
tions. This is particularly relevant to examination of
mutant mice where traditional etiologic or summative
diagnostic terms are simply not available because of the
novelty of the lesion or its presentation. This is particu-
larly the case where mice are manipulated to model hu-
man conditions that have not been previously seen, for
example lung or mammary tumours [11,25,26] which
have not previously been reported to occur spontan-
eously in mice. In many cases, a disease diagnosis im-
plies a particular pathogenesis or etiology based on the
spontaneous disease, which is not appropriate for the
disease caused by genetic and sometimes both genetic
and external challenge combined. This latter issue is of
particular concern to practicing pathologists and in the
development of MPATH we have been urged to include
some diagnostic terms as well as descriptive anatomic
ones.
Many tissue responses are common to multiple ana-
tomical sites and as far as possible the verbosity (ontol-
ogy “bloat”) of specifying a particular response in
multiple tissues has been avoided, with the additional
topographical or anatomical information for descriptioncoming from an anatomy ontology, generally the MA
[27] or EMAP ontologies [28] for the mouse, however,
there is often an intrinsic anatomical element embedded
in the term or traditional pathology includes information
about the cell type or tissue of origin. This is most fre-
quent with the neoplasias and we felt that such terms
were best included in their familiar form. Figure 1B
shows how anatomically predicated classes such as hepa-
tocellular carcinoma have multiple parents, providing re-
lations in this case to both carcinoma and hepatic tumor
superclasses. Most observations made by pathologists
using MPATH are, nevertheless, cross-products using a
combination of an MPATH term and an anatomical
(MA) or cell type (CL) [24,29] component. This strategy
provides all of the necessary coverage.
In addition to the core terms in MPATH, it is import-
ant to describe organ-specific topography, distribution,
microscopic character, duration/chronicity and severity.
These are not included in MPATH but drawn from
other ontologies. These qualifiers or modifiers are gener-
ally applicable across a wide range of organs and lesions
and so need to be coded separately to the core terms to
allow post-composition as required. The pattern we have
adopted is very close to that recommended by the
INHAND proposals and also includes “compound”
terms which lie beneath a definitive diagnosis or disease
level of description, but bundle defined sets of descrip-
tive terms, for example “nephropathy”, “alopecia”, “glom-
erulonephritis” which are in common use and well
understood. These qualifiers have been incorporated into
PATO, and some examples are given in Table 1. The
strategy for composing pathology descriptions using the
combination of MPATH, MA and PATO is summarised
in Figure 2.
Implementation of MPATH coding strategy
The strategy adopted was originally designed to describe
histopathology images for the Pathbase mouse pathology
database [30], but lends itself readily to a wide range of
coding applications. The MPATH strategy has been
adopted by two major high-throughput studies. A com-
bination of MPATH and PATO is being used for the
capture of pathology data from the genome-wide mutant
mouse phenotyping project, KOMP2 run as part of the
International Mouse Phenotyping Consortium [31],
where the MPATH approach is being used in the pri-
mary phenotyping pipeline by the Toronto Centre for
Phenogenomics and other centres carrying out histo-
pathology. MPATH has also been adopted for the
MoDIS database [32] to capture and analyse pathology
data from a massive aging study which has systematically
phenotyped 31 of the most important inbred mouse
strains. Complete necropsies of mice were carried out at
12 and 20 months of age (cross-sectional study) and
Figure 2 Post-composition coding strategy. Elements of the compound description are specified by the string of linked pentagons on the left
hand side of the figure and specific examples given for three observations which taken together are indicative of foreign body pneumonia.
Tissue terms are taken from the appropriate anatomy ontology, eg. MA, Process from MPATH, character, topology, distribution and severity from
PATO. The combination of observations defines the disease foreign body pneumonia.
Table 1 Examples of pathology term qualifiers now incorporated into PATO
Qualifier PATO Class name Definition
Severity 0000461 Normal No lesions
0000394 Mild Lesion dependent; often size, number and characteristics.
0000395 Moderate
0000465 Marked
0000396 Severe
Duration 0002387 Per-acute Extremely acute and aggressive
0000389 Acute Beginning abruptly with marked intensity
0002091 Subacute Between acute and chronic
0001863 Chronic Slow progress and long continuance
0002387 Chronic-active Coexistence of chronic process and superimposed acute process
Distribution 0000627 Focal Single well delineated lesion
0002388 Focally extensive Single lesion with expansion into surrounding tissue
0001791 Multifocal Multiple lesions
0002389 Multifocal to coalescing Multiple lesions some interconnecting with each other
0000330 Random No appreciable pattern
0001566 Diffuse Not circumscribed or limited
0000635 Generalized Affecting all regions without specificity of distribution
0000634 Unilateral Confined to one side only
0000618 Bilateral Involving both sides
0002389 Segmental Relating to a segment
Schofield et al. Journal of Biomedical Semantics 2013, 4:18 Page 5 of 8
http://www.jbiomedsem.com/content/4/1/18
Schofield et al. Journal of Biomedical Semantics 2013, 4:18 Page 6 of 8
http://www.jbiomedsem.com/content/4/1/18moribund mice in the life span (longitudinal study).
Nearly 2,000 mice were necropsied, generating more
than 50,000 slides [33]. Lesion incidence and severity
data for all organs is now being applied in highly suc-
cessful GWAS studies of age-associated disease [33].
MPATH has proved to be additionally useful in deal-
ing with the recoding of multi-species legacy data from
non-standard nomenclatures, permitting integration of
otherwise siloed data. Examples are the European Radio-
logical archive (ERA) database where 6,700 human diag-
noses were recoded from ICD-8 and the Klinischer
Diagnosenschleussel [34] to MPATH/FMA [35], and
with the Northwestern University Janus radiobiology data-
base (http://janus.northwestern.edu/janus2/), who have
coded 50,000 individual mouse records to MPATH to link
the two datasets. Recently the ontology has been applied
to zebrafish phenotype data in the Zfin database [36] indi-
cating a useful application of MPATH to non-mammalian
species which could be developed further.
MPATH as a core ontology for PATO-based logical definitions
The PATO framework was built with the intention of
providing an integration platform for phenotype data be-
tween species and between data types [22]. According to
the PATO framework, phenotype data can be described
by utilising species-specific ontologies (such as the vari-
ous anatomy ontologies) or species-agnostic ontologies
such as GO with the various qualities provided by the
PATO ontology in order to describe affected entities in a
phenotype manifestation. PATO can be used for annota-
tion either directly in a so-called post-composed (post-
coordinated) manner or for providing logical definitions
(equivalence axioms) to ontologies containing a set of pre-
composed (pre-coordinated) phenotype terms [22,37-39].
For further discussion see [40].
Rather than using a pre-composed phenotype ontology
such as MP [29] or HPO [41], phenotypes may be de-
scribed using the Entity–Quality (EQ) formalism. In the
EQ method, a phenotype is characterized by an affected
Entity and a Quality (from PATO) that specifies how the
entity is affected. The affected entity can either be a bio-
logical function or process such as specified in GO, or
an anatomical entity. The phylogenetic conservation, at
least within the amniotes, of most histopathologic lesions
or processes makes MPATH an important core ontology
in writing logical definitions and we have used it exten-
sively in defining classes in the major pre-composed
phenotype ontologies and MPATH is an important com-
ponent ontology of our recently developed semantic ap-
proaches to comparative phenomics – PhenomeNET and
Mousefinder [8,9].
Composition of logical definitions is a time-consuming
task for which there are currently several approaches
to automation using class label segmentation, entityrecognition and lexical matching to core ontologies.
This approach can be useful for suggesting definitions
where the class label is a composite of for example,
anatomy and process (MA +GO). Automated decom-
position of unilexical terms such as are found in the
neoplasias is much more difficult though approaches
with text mining definitions from other ontologies such
as NCIt for lexically matching labels may be useful to
expert curators in establishing more simple definitions
for these classes.
Conclusions
Whilst MPATH was originally designed to support ro-
dent, and particularly mouse, pathology the extensive
overlap with human pathology means that most of the
terms may be used in a human context and linked to the
foundational model of anatomy (FMA) [42] as the anat-
omy ontology. Extending MPATH to become a mamma-
lian pathology ontology encompassing human pathology
is a major undertaking, but we have established that the
current structure and upper level classes would readily
support the inclusion of human terminology. Initially we
will import terms for neoplasias from the CINEAS codes
(Central Information System for Hereditary Diseases and
Synonyms; http://www.cineas.org/; Prof Rolf Sijmons,
pers, comm). SNOMED-CT, UMLS and ICD-O v3 will be
mined for terms not currently in MPATH which relate to
anatomic pathology. Terms already covered by existing
ontologies such as Disease Ontology (DO) [43] may be
referenced using MIREOT [44]. DO classifies diseases
largely by anatomical site and not by disease process or
class, and overlaps only slightly with MPATH as it is
concerned with summative diagnostic entities for the
main part. For example there is no “inflammation” super-
class in DO for the tissue specific inflammatory conditions
described.
Use of MPATH to construct logical definitions for DO
classes would potentially add a further dimension to the
richness and applicability of DO.
The power of the description of pathological lesions to
discriminate between diseases and therefore between
models of human disease is substantial. We recently es-
timated the information content (IC) of pre-composed
MP ontology terms used to code phenotypes in the
EUMODIC mouse phenotyping pipeline [45], which in-
cluded or excluded anatomic pathology descriptions,
using their logical definitions. Pathology-related pheno-
types were shown to have a significantly greater discrimi-
natory power than other in vivo assays, strongly supporting
the use of these assays in the development of mouse models
of human diseases [13].
Further development and application of MPATH will
inevitably depend on community engagement and we
encourage anyone with an interest to provide feedback.
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